Ten biopharmaceutical industry projects have been established in Cangshan with a total investment of 7 billion yuan

"Pharmaceutical Network Industry Dynamics" October 28, Fuzhou City Cumangshan held a biopharmaceutical industry project signing and park centralized start-up operation ceremony, for the "two parks and two centers" unveiled, licensed, and has a total investment of 7 billion 10 biopharmaceutical industry projects successfully signed, for the development of the local biopharmaceutical industry.
It is understood that the so-called "two parks and two centers" is the initial construction of the biopharmaceutical industry carrier pattern in Cangshan, including Caimao Biopharmaceutical Science and Technology Park, Ruike Pharmaceutical Health Industrial Park, Precision and Regenerative Medicine Research Center, Haixi New Drug Research and Development and Transformation Center.
Among them, Caimao Biopharmaceutical Science and Technology Park is located in Jinshan Industrial Park Fuwan District, plans to build a carrier area of 150,000 square meters of biomedical science and technology park, positioning as a high-quality medicine and specialty medical device industry cluster, mainly engaged in new preparations, Chinese medicine health, in-body diagnostic reagents, high-value supplies, household medical devices and other products research and development and production.
precision and regenerative medicine research center building area of about 7200 square meters, has launched the declaration of Fujian Province's high-level innovation platform - Fujian Province Biomedical Laboratory, to create the province's precision and regenerative medicine innovation highland.
Haixi new drug research and development and transformation center construction area of about 6000 square meters, to high-end biopharmaceutical new drug research and development as the core, this year through the first imitation drug consistency evaluation, will be expected to become a business card for the development of the biopharmaceutical industry in Culshan.
has the policy advantage of "six areas overlay", and the biopharmaceutical industry is the pillar industry of the key cultivation and development of the mountain area.
the region from research and development subsidies, talent introduction, financial services and other aspects to support biopharmaceutical enterprises to be bigger and stronger.
the same time, focus on planning and building a number of biopharmaceutical industrial parks, quickly build a headquarters, research and development, production and services in one of the high standards, high-quality, high-output biopharmaceutical industry clusters.
present, the industrial output value of the biomedical regulations in The Scura-Mountain, accounting for about 31% of the city;
Region biopharmaceutical enterprises cover all aspects, including research and development, production and manufacturing and circulation services, with Beijing Tongrentang Health Pharmaceuticals (Fuzhou) Co., Ltd., Fujian Jinshan Biopharmaceutical Co., Ltd., Fujian Xianzhilou Biotech Co., Ltd. and a number of leading enterprises throughout the province and even the country.
Since the beginning of 2020, Cumshan has continued to focus on the cultivation and development of biomedicine as a pillar industry, focusing on high-quality medicine, specialty medical devices, the Internet and medical care three major directions, has introduced more than 60 biopharmaceutical industry, a total investment of more than 30 billion yuan.
including micro-medical groups, Yinfeng Bio and other unicorn enterprises, but also Caimao Biopharmaceuticals, Ruike Pharmaceutical Health and other industrial park projects.
According to the "Scangshan Biopharmaceutical Industry Development Plan (2020-2030)" prepared by The District will strive to achieve a biopharmaceutical industry scale of more than 50 billion yuan by 2025, and form a biopharmaceutical industry cluster of 100 billion yuan by 2030, which will build Cangshan into a high density of biopharmaceutical enterprises in Fuzhou City and Even Fujian Province, where talents converge to the highest, innovative and dynamic industrial development cluster.
It is learned that the next step, Cangshan will fully declare the international medical comprehensive experimental zone, and around the "two parks and two centers" research to introduce relevant support policies, in order to do more to promote the biopharmaceutical industry park-style, cluster-style development.